Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 71

1.

Author response: Nationwide prevalence and incidence study of neuromyelitis optica spectrum disorder in Denmark.

Papp V, Illes Z, Magyari M, Koch-Henriksen N, Frederiksen JL, Sellebjerg F, Stenager E, Petersen T.

Neurology. 2019 Oct 15;93(16):723. doi: 10.1212/WNL.0000000000008324. No abstract available.

PMID:
31611317
2.

A population-based epidemiological study of neuromyelitis optica spectrum disorder in Hungary.

Papp V, Iljicsov A, Rajda C, Magyari M, Koch-Henriksen N, Petersen T, Jakab G, Deme I, Nagy F, Imre P, Lohner Z, Kovács K, Birkás AJ, Köves Á, Rum G, Nagy Z, Kerényi L, Vécsei L, Bencsik K, Jobbágy Z, Diószeghy P, Horváth L, Galántai G, Kasza J, Molnár G, Simó M, Sátori M, Rózsa C, Ács P, Berki T, Lovas G, Komoly S, Illes Z.

Eur J Neurol. 2019 Aug 29. doi: 10.1111/ene.14079. [Epub ahead of print]

PMID:
31465603
3.

Incidence of pediatric neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein antibody-associated disease in Denmark 2008‒2018: A nationwide, population-based cohort study.

Boesen MS, Jensen PEH, Born AP, Magyari M, Nilsson AC, Hoei-Hansen C, Blinkenberg M, Sellebjerg F.

Mult Scler Relat Disord. 2019 Aug;33:162-167. doi: 10.1016/j.msard.2019.06.002. Epub 2019 Jun 5.

PMID:
31276927
4.

Reproductive history of the Danish multiple sclerosis population: A register-based study.

Moberg JY, Laursen B, Thygesen LC, Magyari M.

Mult Scler. 2019 May 30:1352458519851245. doi: 10.1177/1352458519851245. [Epub ahead of print]

PMID:
31144565
5.

Illegal cannabis use is common among Danes with multiple sclerosis.

Gustavsen S, Søndergaard HB, Andresen SR, Magyari M, Sørensen PS, Sellebjerg F, Oturai AB.

Mult Scler Relat Disord. 2019 Aug;33:5-12. doi: 10.1016/j.msard.2019.05.008. Epub 2019 May 16.

PMID:
31129415
6.

Changes in the sex ratio are a good indicator of changes in MS incidence - No.

Magyari M, Koch-Henriksen N.

Mult Scler. 2019 Oct;25(12):1568-1569. doi: 10.1177/1352458519837926. Epub 2019 May 15. No abstract available.

PMID:
31088314
7.

Multiple sclerosis among first- and second-generation immigrants in Denmark: a population-based cohort study.

Munk Nielsen N, Corn G, Frisch M, Stenager E, Koch-Henriksen N, Wohlfahrt J, Magyari M, Melbye M.

Brain. 2019 Jun 1;142(6):1587-1597. doi: 10.1093/brain/awz088.

PMID:
31081503
8.

Predictors of treatment outcome in patients with paediatric onset multiple sclerosis.

Kopp TI, Blinkenberg M, Chalmer TA, Petersen T, Ravnborg MH, Soelberg Sørensen P, Magyari M.

Mult Scler. 2019 May 13:1352458519846100. doi: 10.1177/1352458519846100. [Epub ahead of print]

PMID:
31081451
9.

Management strategies for female patients of reproductive potential with multiple sclerosis: An evidence-based review.

Coyle PK, Oh J, Magyari M, Oreja-Guevara C, Houtchens M.

Mult Scler Relat Disord. 2019 Jul;32:54-63. doi: 10.1016/j.msard.2019.04.003. Epub 2019 Apr 5. Review.

10.

Worsening of disability caused by relapses in multiple sclerosis: A different approach.

Koch-Henriksen N, Thygesen LC, Sørensen PS, Magyari M.

Mult Scler Relat Disord. 2019 Jul;32:1-8. doi: 10.1016/j.msard.2019.04.017. Epub 2019 Apr 15.

PMID:
31003200
11.

The changing course of multiple sclerosis: rising incidence, change in geographic distribution, disease course, and prognosis.

Magyari M, Sorensen PS.

Curr Opin Neurol. 2019 Jun;32(3):320-326. doi: 10.1097/WCO.0000000000000695.

PMID:
30925518
12.

Comparative effectiveness of teriflunomide and dimethyl fumarate: A nationwide cohort study.

Buron MD, Chalmer TA, Sellebjerg F, Frederiksen J, Góra MK, Illes Z, Kant M, Mezei Z, Petersen T, Rasmussen PV, Roshanisefat H, Hassanpour-Kalam-Roudy H, Sejbæk T, Tsakiri A, Weglewski A, Sorensen PS, Magyari M.

Neurology. 2019 Apr 16;92(16):e1811-e1820. doi: 10.1212/WNL.0000000000007314. Epub 2019 Mar 15.

PMID:
30877188
13.

Multiple sclerosis and cancer incidence: A Danish nationwide cohort study.

Nørgaard M, Veres K, Didden EM, Wormser D, Magyari M.

Mult Scler Relat Disord. 2019 Feb;28:81-85. doi: 10.1016/j.msard.2018.12.014. Epub 2018 Dec 14.

PMID:
30576846
14.

Draft Genome Sequence of Propionibacterium acnes subsp. elongatum Strain Asn12.

McDowell A, Hunyadkürti J, Magyari M, Vörös A, Horváth B, Patrick S, Nagy I.

Microbiol Resour Announc. 2018 Jul 19;7(2). pii: e00801-18. doi: 10.1128/MRA.00801-18. eCollection 2018 Jul.

15.

Pregnancy Outcomes in Men and Women Treated With Teriflunomide. A Population-Based Nationwide Danish Register Study.

Andersen JB, Moberg JY, Spelman T, Magyari M.

Front Immunol. 2018 Nov 23;9:2706. doi: 10.3389/fimmu.2018.02706. eCollection 2018.

16.

Treatment escalation leads to fewer relapses compared with switching to another moderately effective therapy.

Chalmer TA, Kalincik T, Laursen B, Sorensen PS, Magyari M; Members of Danish Multiple Sclerosis Group.

J Neurol. 2019 Feb;266(2):306-315. doi: 10.1007/s00415-018-9126-y. Epub 2018 Dec 4.

PMID:
30515628
17.

Nationwide prevalence and incidence study of neuromyelitis optica spectrum disorder in Denmark.

Papp V, Illes Z, Magyari M, Koch-Henriksen N, Kant M, Pfleger CC, Roemer SF, Jensen MB, Petersen AE, Nielsen HH, Rosendahl L, Mezei Z, Christensen T, Svendsen K, Hyldgaard Jensen PE, Lydolph MC, Heegaard N, Frederiksen JL, Sellebjerg F, Stenager E, Petersen T.

Neurology. 2018 Dec 11;91(24):e2265-e2275. doi: 10.1212/WNL.0000000000006645. Epub 2018 Nov 9.

18.

Multiple sclerosis registries in Europe - An updated mapping survey.

Glaser A, Stahmann A, Meissner T, Flachenecker P, Horáková D, Zaratin P, Brichetto G, Pugliatti M, Rienhoff O, Vukusic S, de Giacomoni AC, Battaglia MA, Brola W, Butzkueven H, Casey R, Drulovic J, Eichstädt K, Hellwig K, Iaffaldano P, Ioannidou E, Kuhle J, Lycke K, Magyari M, Malbaša T, Middleton R, Myhr KM, Notas K, Orologas A, Otero-Romero S, Pekmezovic T, Sastre-Garriga J, Seeldrayers P, Soilu-Hänninen M, Stawiarz L, Trojano M, Ziemssen T, Hillert J, Thalheim C.

Mult Scler Relat Disord. 2019 Jan;27:171-178. doi: 10.1016/j.msard.2018.09.032. Epub 2018 Oct 4. No abstract available.

PMID:
30384204
19.

Mental health among children of mothers with multiple sclerosis: A Danish cohort and register-based study.

Andersen JB, Moberg JY, Niclasen J, Laursen B, Magyari M.

Brain Behav. 2018 Oct;8(10):e01098. doi: 10.1002/brb3.1098. Epub 2018 Sep 21.

20.

Alcohol consumption in adolescence is associated with a lower risk of multiple sclerosis in a Danish cohort.

Andersen C, Søndergaard HB, Bang Oturai D, Laursen JH, Gustavsen S, Larsen NK, Magyari M, Just-Østergaard E, Thørner LW, Sellebjerg F, Ullum H, Oturai AB.

Mult Scler. 2019 Oct;25(12):1572-1579. doi: 10.1177/1352458518795418. Epub 2018 Aug 20.

PMID:
30124094
21.

Increased cerebrospinal fluid chitinase 3-like 1 and neurofilament light chain in pediatric acquired demyelinating syndromes.

Boesen MS, Jensen PEH, Magyari M, Born AP, Uldall PV, Blinkenberg M, Sellebjerg F.

Mult Scler Relat Disord. 2018 Aug;24:175-183. doi: 10.1016/j.msard.2018.05.017. Epub 2018 Jun 11.

PMID:
30055504
22.

Patient awareness about family planning represents a major knowledge gap in multiple sclerosis.

Rasmussen PV, Magyari M, Moberg JY, Bøgelund M, Jensen UFA, Madsen KG.

Mult Scler Relat Disord. 2018 Aug;24:129-134. doi: 10.1016/j.msard.2018.06.006. Epub 2018 Jun 15.

23.

Early versus later treatment start in multiple sclerosis: a register-based cohort study.

Chalmer TA, Baggesen LM, Nørgaard M, Koch-Henriksen N, Magyari M, Sorensen PS; Danish Multiple Sclerosis Group.

Eur J Neurol. 2018 Oct;25(10):1262-e110. doi: 10.1111/ene.13692. Epub 2018 Jul 9.

PMID:
29847005
24.

Infections seem to be more frequent before onset of pediatric multiple sclerosis: A Danish nationwide nested case-control study.

Boesen MS, Koch-Henriksen N, Thygesen LC, Eriksson F, Greisen G, Born AP, Blinkenberg M, Uldall PV, Magyari M.

Mult Scler. 2019 May;25(6):783-791. doi: 10.1177/1352458518771871. Epub 2018 May 17.

PMID:
29770725
25.

Small-scale geographical variation in multiple sclerosis: A case-control study using Danish register data 1971-2013.

Bihrmann K, Nielsen NM, Magyari M, Koch-Henriksen N, Nordsborg RB, Ersbøll AK.

Mult Scler Relat Disord. 2018 Jul;23:40-45. doi: 10.1016/j.msard.2018.04.021. Epub 2018 May 4.

26.

Implications of the International Paediatric Multiple Sclerosis Study Group consensus criteria for paediatric acute disseminated encephalomyelitis: a nationwide validation study.

Boesen MS, Blinkenberg M, Koch-Henriksen N, Thygesen LC, Uldall PV, Magyari M, Born AP.

Dev Med Child Neurol. 2018 Nov;60(11):1123-1131. doi: 10.1111/dmcn.13798. Epub 2018 May 10.

PMID:
29744874
27.

Incidence of MS has increased markedly over six decades in Denmark particularly with late onset and in women.

Koch-Henriksen N, Thygesen LC, Stenager E, Laursen B, Magyari M.

Neurology. 2018 May 29;90(22):e1954-e1963. doi: 10.1212/WNL.0000000000005612. Epub 2018 May 2.

PMID:
29720546
28.

Pediatric acquired demyelinating syndromes: a nationwide validation study of the Danish National Patient Register.

Boesen MS, Magyari M, Born AP, Thygesen LC.

Clin Epidemiol. 2018 Apr 10;10:391-399. doi: 10.2147/CLEP.S156997. eCollection 2018.

29.

Progressive multiple sclerosis, cognitive function, and quality of life.

Højsgaard Chow H, Schreiber K, Magyari M, Ammitzbøll C, Börnsen L, Romme Christensen J, Ratzer R, Soelberg Sørensen P, Sellebjerg F.

Brain Behav. 2018 Jan 5;8(2):e00875. doi: 10.1002/brb3.875. eCollection 2018 Feb.

30.

Smoking affects the interferon beta treatment response in multiple sclerosis.

Petersen ER, Oturai AB, Koch-Henriksen N, Magyari M, Sørensen PS, Sellebjerg F, Søndergaard HB.

Neurology. 2018 Feb 13;90(7):e593-e600. doi: 10.1212/WNL.0000000000004949. Epub 2018 Jan 17.

PMID:
29343473
31.

Disability in progressive MS is associated with T2 lesion changes.

Ammitzbøll C, Dyrby TB, Lyksborg M, Schreiber K, Ratzer R, Romme Christensen J, Iversen P, Magyari M, Garde E, Sørensen PS, Siebner HR, Sellebjerg F.

Mult Scler Relat Disord. 2018 Feb;20:73-77. doi: 10.1016/j.msard.2017.12.010. Epub 2017 Dec 18.

PMID:
29324249
32.

Psychiatric morbidity develops after onset of pediatric multiple sclerosis: A Danish nationwide population-based study.

Boesen MS, Thygesen LC, Uldall PV, Eriksson F, Born AP, Blinkenberg M, Koch-Henriksen N, Greisen G, Magyari M.

Mult Scler Relat Disord. 2018 Jan;19:30-34. doi: 10.1016/j.msard.2017.10.018. Epub 2017 Oct 31.

PMID:
29121513
33.

Male factor infertility and risk of multiple sclerosis: A register-based cohort study.

Glazer CH, Tøttenborg SS, Giwercman A, Bräuner EV, Eisenberg ML, Vassard D, Magyari M, Pinborg A, Schmidt L, Bonde JP.

Mult Scler. 2017 Oct 1:1352458517734069. doi: 10.1177/1352458517734069. [Epub ahead of print]

PMID:
29027840
34.

Comorbidity in multiple sclerosis is associated with diagnostic delays and increased mortality.

Thormann A, Sørensen PS, Koch-Henriksen N, Laursen B, Magyari M.

Neurology. 2017 Oct 17;89(16):1668-1675. doi: 10.1212/WNL.0000000000004508. Epub 2017 Sep 20.

PMID:
28931645
35.

Excess mortality among patients with multiple sclerosis in Denmark has dropped significantly over the past six decades: a population based study.

Koch-Henriksen N, Laursen B, Stenager E, Magyari M.

J Neurol Neurosurg Psychiatry. 2017 Aug;88(8):626-631. doi: 10.1136/jnnp-2017-315907.

PMID:
28705951
36.

Pediatric-onset multiple sclerosis and other acquired demyelinating syndromes of the central nervous system in Denmark during 1977-2015: A nationwide population-based incidence study.

Boesen MS, Magyari M, Koch-Henriksen N, Thygesen LC, Born AP, Uldall PV, Blinkenberg M.

Mult Scler. 2018 Jul;24(8):1077-1086. doi: 10.1177/1352458517713669. Epub 2017 Jun 13.

PMID:
28608742
37.

Chronic comorbidity in multiple sclerosis is associated with lower incomes and dissolved intimate relationships.

Thormann A, Sørensen PS, Koch-Henriksen N, Thygesen LC, Laursen B, Magyari M.

Eur J Neurol. 2017 Jun;24(6):825-834. doi: 10.1111/ene.13297.

PMID:
28544411
38.

Genetic burden of MS risk variants distinguish patients from healthy individuals but are not associated with disease activity.

Søndergaard HB, Petersen ER, Magyari M, Sellebjerg F, Oturai AB.

Mult Scler Relat Disord. 2017 Apr;13:25-27. doi: 10.1016/j.msard.2017.01.015. Epub 2017 Jan 31.

PMID:
28427696
39.

Age at Menarche and Risk of Multiple Sclerosis: A Prospective Cohort Study Based on the Danish National Birth Cohort.

Nielsen NM, Harpsøe M, Simonsen J, Stenager E, Magyari M, Koch-Henriksen N, Baker JL, Hjalgrim H, Frisch M, Bager P.

Am J Epidemiol. 2017 Apr 15;185(8):712-719. doi: 10.1093/aje/kww160.

PMID:
28369233
40.

Inverse comorbidity in multiple sclerosis: Findings in a complete nationwide cohort.

Thormann A, Koch-Henriksen N, Laursen B, Sørensen PS, Magyari M.

Mult Scler Relat Disord. 2016 Nov;10:181-186. doi: 10.1016/j.msard.2016.10.008. Epub 2016 Oct 29.

PMID:
27919487
41.

Early safety and efficacy of fingolimod treatment in Denmark.

Voldsgaard A, Koch-Henriksen N, Magyari M, Sellebjerg F, Sørensen PS, Oturai AB.

Acta Neurol Scand. 2017 Jan;135(1):129-133. doi: 10.1111/ane.12573. Epub 2016 Mar 8.

PMID:
27910101
42.

Neonatal vitamin D status and risk of multiple sclerosis: A population-based case-control study.

Nielsen NM, Munger KL, Koch-Henriksen N, Hougaard DM, Magyari M, Jørgensen KT, Lundqvist M, Simonsen J, Jess T, Cohen A, Stenager E, Ascherio A.

Neurology. 2017 Jan 3;88(1):44-51. doi: 10.1212/WNL.0000000000003454. Epub 2016 Nov 30.

43.

The Danish Multiple Sclerosis Treatment Register.

Magyari M, Koch-Henriksen N, Sørensen PS.

Clin Epidemiol. 2016 Oct 25;8:549-552. eCollection 2016. Review.

44.

Vascular comorbidities in multiple sclerosis: a nationwide study from Denmark.

Thormann A, Magyari M, Koch-Henriksen N, Laursen B, Sørensen PS.

J Neurol. 2016 Dec;263(12):2484-2493. Epub 2016 Oct 3.

PMID:
27699465
45.

Employment, disability pension and income for children with parental multiple sclerosis.

Moberg JY, Laursen B, Koch-Henriksen N, Thygesen LC, Brødsgaard A, Soelberg Sørensen P, Magyari M.

Mult Scler. 2017 Jul;23(8):1148-1156. doi: 10.1177/1352458516672016. Epub 2016 Sep 28.

PMID:
27682230
46.

Shift work at young age is associated with increased risk of multiple sclerosis in a Danish population.

Gustavsen S, Søndergaard HB, Oturai DB, Laursen B, Laursen JH, Magyari M, Ullum H, Larsen MH, Sellebjerg F, Oturai AB.

Mult Scler Relat Disord. 2016 Sep;9:104-9. doi: 10.1016/j.msard.2016.06.010. Epub 2016 Jun 27.

PMID:
27645354
47.

Educational achievements of children of parents with multiple sclerosis: A nationwide register-based cohort study.

Moberg JY, Magyari M, Koch-Henriksen N, Thygesen LC, Laursen B, Soelberg Sørensen P.

J Neurol. 2016 Nov;263(11):2229-2237. Epub 2016 Aug 19.

PMID:
27541043
48.

High-dose erythropoietin in patients with progressive multiple sclerosis: A randomized, placebo-controlled, phase 2 trial.

Schreiber K, Magyari M, Sellebjerg F, Iversen P, Garde E, Madsen CG, Börnsen L, Romme Christensen J, Ratzer R, Siebner HR, Laursen B, Soelberg Sorensen P.

Mult Scler. 2017 Apr;23(5):675-685. doi: 10.1177/1352458516661048. Epub 2016 Aug 5.

PMID:
27481206
49.

A comparison of multiple sclerosis clinical disease activity between patients treated with natalizumab and fingolimod.

Koch-Henriksen N, Magyari M, Sellebjerg F, Soelberg Sørensen P.

Mult Scler. 2017 Feb;23(2):234-241. doi: 10.1177/1352458516643393. Epub 2016 Jul 11.

PMID:
27055806
50.

Gender differences in multiple sclerosis epidemiology and treatment response.

Magyari M.

Dan Med J. 2016 Mar;63(3). pii: B5212. Review.

PMID:
26931196

Supplemental Content

Loading ...
Support Center